Picard Medical, Inc. - 8-K Filing
Picard Medical reported Q1 2026 revenue of $1.2 million (up from $0.6 million YoY), with gross profit turning positive at $0.3 million (24% margin) after a prior-year loss, and executed significant debt reduction actions including repaying $7.4 million in senior secured notes and settling $2.1 million via equity issuance. The company received two NYSE American delisting notices for failing continued listing standards due to insufficient stockholders' equity ($3.8M as of Dec 2025, -$1.4M as of Mar 2026) amid ongoing losses in multiple fiscal years and must submit a compliance plan by June 7, 20... (Items: 2.02 of Form 8-K, “Results of Operations and Financial Condition, 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $PMI